Literature DB >> 1393271

The role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbits.

P Vallance1, R M Palmer, S Moncada.   

Abstract

1. Endotoxaemia is characterized by hypotension, peripheral vasodilatation and a reduced response to vasoconstrictors. Clinical studies have indicated that venodilatation contributes to the haemodynamic changes, although there is no direct evidence for abnormal venous reactivity. In the present study, the role of nitric oxide (NO) in modifying the responses of rabbit isolated jugular veins was examined in vitro, 4 h after intravenous injection of endotoxin. 2. Treatment with endotoxin reduced the contractile response to the thromboxane-mimetic, 9,11-dideoxy-11 alpha, 9 alpha-epoxymethano-prostaglandin F2 alpha (U-46619). This affect was endothelium-independent. The response was partially restored by the NO synthase inhibitor. NG-monomethyl-L-arginine (L-NMMA 300 microM). 3. Jugular veins from control animals did not contract to L-NMMA whereas those from endotoxin-treated animals showed concentration-dependent contractions to L-NMMA. The contractions produced by L-NMMA were reversed by L-arginine but not by D-arginine. Treatment of the animals with dexamethasone (4 mg kg-1) 1 h prior to administration of endotoxin significantly attenuated the response to L-NMMA. 4. The response to sodium nitroprusside did not differ significantly between veins from control and endotoxin-treated animals. Endothelial denudation did not alter the sensitivity of the veins to sodium nitroprusside. Acetylcholine produced endothelium-dependent relaxations which were similar in veins from control and endotoxin-treated animals. 5. The results of this study demonstrate that intravenous administration of endotoxin induces hyporesponsiveness to U-46619 in jugular veins. This effect is mediated, at least in part, by the induction of NO synthesis in smooth muscle. The induction is prevented by prior treatment with dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393271      PMCID: PMC1907499          DOI: 10.1111/j.1476-5381.1992.tb14356.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells.

Authors:  I Fleming; G A Gray; C Schott; J C Stoclet
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

2.  HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION.

Authors:  S E Bradley; H Chasis; W Goldring; H W Smith
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

3.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 4.  Local control of human peripheral vascular tone: implications for drug therapy.

Authors:  N Benjamin; P Vallance
Journal:  Clin Sci (Lond)       Date:  1991-03       Impact factor: 6.124

5.  Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.

Authors:  C Thiemermann; J Vane
Journal:  Eur J Pharmacol       Date:  1990-07-17       Impact factor: 4.432

6.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.

Authors:  D D Rees; S Cellek; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

7.  Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein.

Authors:  Z H Yang; L von Segesser; E Bauer; P Stulz; M Turina; T F Lüscher
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

8.  The cardiovascular response of normal humans to the administration of endotoxin.

Authors:  A F Suffredini; R E Fromm; M M Parker; M Brenner; J A Kovacs; R A Wesley; J E Parrillo
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

9.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

10.  Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

View more
  6 in total

1.  Impaired in vivo venous constriction in conscious obese Zucker rats with metabolic syndrome.

Authors:  Dongzhe Song; Simon R Hutchings; Catherine C Y Pang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-31       Impact factor: 3.000

2.  Cutaneous venous dysfunction studied in vivo in the LPS-treated rabbit: implication of NO in saphenous vein hyporeactivity.

Authors:  Christine Vayssettes-Courchay; Marta Chataigneau; Cedric Protin; Christophe Ragonnet; Tony J Verbeuren
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-02       Impact factor: 3.000

3.  Regulation of nitric oxide-like activity by prostanoids in smooth muscle of the canine saphenous vein.

Authors:  S Illiano; R Marsault; J J Descombes; T Verbeuren; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  A genome-wide association study of the human metabolome in a community-based cohort.

Authors:  Eugene P Rhee; Jennifer E Ho; Ming-Huei Chen; Dongxiao Shen; Susan Cheng; Martin G Larson; Anahita Ghorbani; Xu Shi; Iiro T Helenius; Christopher J O'Donnell; Amanda L Souza; Amy Deik; Kerry A Pierce; Kevin Bullock; Geoffrey A Walford; Ramachandran S Vasan; Jose C Florez; Clary Clish; J-R Joanna Yeh; Thomas J Wang; Robert E Gerszten
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

5.  Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin.

Authors:  J Brandon Thomas; Frederick W Holtsberg; C Mark Ensor; John S Bomalaski; Mike A Clark
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

6.  Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.